Venture Capital Archives - Page 80 of 103

PureTech Launches Celea Therapeutics to Advance Treatment of Serious Respiratory Diseases

August 12, 2025

First Patient Dosed in Phase 3 Trial of Potential Dravet Syndrome Treatment

August 11, 2025

Boston IVF Adds Dr. Mary Morris to Massachusetts Fertility Team, Expanding Expertise in Oncofertility and Family Building

August 7, 2025

THIS WEEK'S STORIES

Boston IVF Adds Dr. Mary Morris to Massachusetts Fertility Team, Expanding Expertise in Oncofertility and Family Building

August 7, 2025

Survey Finds Pediatricians Prefer Genexa’s Ingredient Profiles Over Children’s Tylenol® Products

August 13, 2025

First FDA-Approved Treatment for MacTel Administered Following Commercial Launch

August 11, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Venture Capital

SetPoint Medical Secures $140 Million to Advance Rheumatoid Arthritis Therapy, Expands Leadership Team

Apreo Health Raises $130 Million in Series B to Advance Trial and Commercialization of Novel Emphysema Device

Strand Therapeutics Secures $153 Million in Series B to Accelerate Programmable mRNA Therapy Pipeline

AVS Bio Acquires IPA Europe to Boost Antibody Discovery and Protein Production Capabilities

Frazier Life Sciences Closes $1.3 Billion Fund to Back Early-Stage Biotech Ventures

Most Read

KnoWEwell Names Functional Medicine Leader Dr. Patrick Hanaway as Chief Medical Officer

Survey Finds Pediatricians Prefer Genexa’s Ingredient Profiles Over Children’s Tylenol® Products

FDA Grants De Novo Authorization to ArteraAI Prostate, First AI-Powered Digital Pathology Tool for Prostate Cancer Prognosis

Alto Neuroscience Appoints Raymond Sanchez, M.D., to Board of Directors

EDITOR PICKS

PureTech Launches Celea Therapeutics to Advance Treatment of Serious Respiratory Diseases

First Patient Dosed in Phase 3 Trial of Potential Dravet Syndrome Treatment

Boston IVF Adds Dr. Mary Morris to Massachusetts Fertility Team, Expanding Expertise in Oncofertility and Family Building

THIS WEEK'S STORIES

Boston IVF Adds Dr. Mary Morris to Massachusetts Fertility Team, Expanding Expertise in Oncofertility and Family Building

Survey Finds Pediatricians Prefer Genexa’s Ingredient Profiles Over Children’s Tylenol® Products

First FDA-Approved Treatment for MacTel Administered Following Commercial Launch

POPULAR CATEGORY

ABOUT US

FOLLOW US